Literature DB >> 22681248

Allosteric modulation of protease-activated receptor signaling.

I Canto1, U J K Soh, J Trejo.   

Abstract

The protease-activated receptors (PARs) are G protein-coupled receptors (GPCRs) that are uniquely activated by proteolysis. PARs mediate hemostasis, thrombosis, inflammation, embryonic development and progression of certain malignant cancers. The family of PARs include four members: PAR1, PAR2, PAR3 and PAR4. PARs harbor a cryptic ligand sequence within their N-terminus that is exposed following proteolytic cleavage. The newly formed PAR Nterminus functions as a tethered ligand that binds intramolecularly to the receptor to trigger transmembrane signaling. This unique mechanism of activation would indicate that regardless of the activating protease, cleavage of PARs would unmask a tethered ligand sequence that would induce a similar active receptor conformation and signaling response. However, this is not the case. Recent studies demonstrate that PARs can be differentially activated by synthetic peptide agonists, proteases or through dimerization, that ultimately result in distinct cellular responses. In some cases, allosteric modulation of PARs involves compartmentalization in caveolae, plasma membrane microdomains enriched in cholesterol. Here, we discuss some mechanisms that lead to allosteric modulation of PAR signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22681248      PMCID: PMC4237590          DOI: 10.2174/138955712800959116

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  69 in total

1.  Substrate specificities of matrix metalloproteinase 1 in PAR-1 exodomain proteolysis.

Authors:  Antonella Nesi; Marco Fragai
Journal:  Chembiochem       Date:  2007-08-13       Impact factor: 3.164

2.  The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells.

Authors:  Jong-Sup Bae; Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Blood       Date:  2007-09-06       Impact factor: 22.113

3.  Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells.

Authors:  J-S Bae; L Yang; A R Rezaie
Journal:  J Thromb Haemost       Date:  2008-02-12       Impact factor: 5.824

4.  Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathways.

Authors:  Xiaoling Deng; Paul F Mercer; Chris J Scotton; Annette Gilchrist; Rachel C Chambers
Journal:  Mol Biol Cell       Date:  2008-03-19       Impact factor: 4.138

5.  Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells.

Authors:  Katsuya Hirano; Namie Nomoto; Mayumi Hirano; Fumi Momota; Akiko Hanada; Hideo Kanaide
Journal:  J Pharmacol Exp Ther       Date:  2007-05-09       Impact factor: 4.030

Review 6.  Dual regulation of endothelial junctional permeability.

Authors:  Yulia A Komarova; Dolly Mehta; Asrar B Malik
Journal:  Sci STKE       Date:  2007-11-13

7.  'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage.

Authors:  Nicole C Kaneider; Andrew J Leger; Anika Agarwal; Nga Nguyen; George Perides; Claudia Derian; Lidija Covic; Athan Kuliopulos
Journal:  Nat Immunol       Date:  2007-10-28       Impact factor: 25.606

8.  Agonist-selective signaling is determined by the receptor location within the membrane domains.

Authors:  Hui Zheng; Ji Chu; Yu Qiu; Horace H Loh; Ping-Yee Law
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-01       Impact factor: 11.205

9.  Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.

Authors:  Reto A Schuepbach; Clemens Feistritzer; Lawrence F Brass; Matthias Riewald
Journal:  Blood       Date:  2007-12-18       Impact factor: 22.113

10.  Localization of the mouse 5-hydroxytryptamine(1A) receptor in lipid microdomains depends on its palmitoylation and is involved in receptor-mediated signaling.

Authors:  Ute Renner; Konstantin Glebov; Thorsten Lang; Ekaterina Papusheva; Saju Balakrishnan; Bernhard Keller; Diethelm W Richter; Reinhard Jahn; Evgeni Ponimaskin
Journal:  Mol Pharmacol       Date:  2007-05-31       Impact factor: 4.436

View more
  10 in total

1.  Characterization of thrombin-bound dabigatran effects on protease-activated receptor-1 expression and signaling in vitro.

Authors:  Buxin Chen; Antonio G Soto; Luisa J Coronel; Ashley Goss; Joanne van Ryn; JoAnn Trejo
Journal:  Mol Pharmacol       Date:  2015-05-01       Impact factor: 4.436

Review 2.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

3.  Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.

Authors:  Ruchika Sharma; Amanda P Waller; Shipra Agrawal; Katelyn J Wolfgang; Hiep Luu; Khurrum Shahzad; Berend Isermann; William E Smoyer; Marvin T Nieman; Bryce A Kerlin
Journal:  J Am Soc Nephrol       Date:  2017-04-19       Impact factor: 10.121

4.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 5.  Cytoprotective-selective activated protein C therapy for ischaemic stroke.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Thromb Haemost       Date:  2014-09-18       Impact factor: 5.249

6.  Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering.

Authors:  Andrea N Flynn; Justin Hoffman; Dipti V Tillu; Cara L Sherwood; Zhenyu Zhang; Renata Patek; Marina N K Asiedu; Josef Vagner; Theodore J Price; Scott Boitano
Journal:  FASEB J       Date:  2013-01-04       Impact factor: 5.191

Review 7.  Targeting PAR1: Now What?

Authors:  Robert Flaumenhaft; Karen De Ceunynck
Journal:  Trends Pharmacol Sci       Date:  2017-05-27       Impact factor: 14.819

8.  Vascular Endothelial Cells Produce Coagulation Factors That Control Their Growth via Joint Protease-Activated Receptor and C5a Receptor 1 (CD88) Signaling.

Authors:  Devin Cao; Michael G Strainic; Daniel Counihan; Shiva Sridar; Fengqi An; Wasim Hussain; Alvin H Schmaier; Marvin Nieman; M Edward Medof
Journal:  Am J Pathol       Date:  2022-02       Impact factor: 4.307

9.  Recycling and Endosomal Sorting of Protease-activated Receptor-1 Is Distinctly Regulated by Rab11A and Rab11B Proteins.

Authors:  Neil J Grimsey; Luisa J Coronel; Isabel Canto Cordova; JoAnn Trejo
Journal:  J Biol Chem       Date:  2015-12-03       Impact factor: 5.157

10.  PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury.

Authors:  Karen De Ceunynck; Christian G Peters; Abhishek Jain; Sarah J Higgins; Omozuanvbo Aisiku; Jennifer L Fitch-Tewfik; Sharjeel A Chaudhry; Chris Dockendorff; Samir M Parikh; Donald E Ingber; Robert Flaumenhaft
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-17       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.